Don't miss an issue! Renew/subscribe for FREE today.
×

Genetic Risk Assessment for Periodontal Disease Highlighted During ADA Annual Meeting

Posted on Tuesday, October 14, 2014

WALTHAM, Mass. – October 13, 2014 – The topic of genetics in relation to periodontal disease was a focus at the 2014 American Dental Association (ADA) Annual Meeting, according to Interleukin Genetics, Inc.

During a Saturday morning continuing education course titled, “Introduce Scientific Advances Into Your Clinical Practice,” Interleukin’s CEO Kenneth S. Kornman, DDS, PhD presented on the topic of genetic testing as part of risk stratification for preventive dental care.

Heightened interest in the subject results from the landmark research published in the Journal of Dental Research (June 2013). The University of Michigan Personalized Prevention Study provided important new insights into the prevention of periodontal disease and the significant opportunity to improve oral health through a personalized approach to preventive care that includes genetics. Last month, the study’s authors received the 2014 Clinical Research Award from the American Academy of Periodontology demonstrating the impact of this research on clinical dentistry.

During the ADA annual meeting Dr. Kornman was also presented with a 2014 DrBicuspid Dental Excellence Award, naming PerioPredict® “Best New Hygienist Product.” The Dental Excellence Awards recognize the very best people, products and services that are helping to improve dental health.  The votes are cast by members of the DrBicuspid.com professional community and DrBicuspid.com readers, and honor the best of what dentistry has to offer.

“We’re truly honored that PerioPredict® has been recognized with an award by the members of DrBicuspid.com. I am also pleased that the ADA has chosen to dedicate a CE session to the important topic of genetic testing, including the research that supports use of genetics as part of a personalized risk-based approach to preventive care” said Dr. Kornman. “The concept of personalized medicine is not new, but current tools, especially in genomics, now allow us to identify and stratify patients with greater precision. This research is opening new doors for the dental profession in terms of optimizing patient care and early identification and prevention of severe periodontitis in patients who are at increased risk. 







Recent Headlines

© 2024 Conexiant | Privacy Policy